Dexelvucitabine
Dexelvucitabine
Dexelvucitabine (pronunciation: dex-el-vu-ci-ta-bine) is a nucleoside reverse transcriptase inhibitor (NRTI) that was previously under investigation for the treatment of HIV and AIDS.
Etymology
The term "Dexelvucitabine" is derived from the chemical structure of the drug. The prefix "Dex-" refers to the dextrorotatory isomer, "-elvu-" is an abbreviation of the chemical name, and "-citabine" is a common suffix for cytidine analogues, which are a type of NRTI.
Mechanism of Action
Dexelvucitabine inhibits the action of reverse transcriptase, an enzyme that HIV uses to replicate its genetic material. By blocking this enzyme, dexelvucitabine can help to reduce the amount of HIV in the body.
Related Terms
- Nucleoside reverse transcriptase inhibitors: A class of antiretroviral drugs that includes dexelvucitabine.
- Reverse transcriptase: An enzyme that HIV uses to replicate its genetic material.
- HIV: The virus that causes AIDS.
- AIDS: A disease caused by HIV, which weakens the immune system.
See Also
External links
- Medical encyclopedia article on Dexelvucitabine
- Wikipedia's article - Dexelvucitabine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski